從高級白內障手術市場報告(2025年):2024年到2030年前幾名13個國家的分析
市場調查報告書
商品編碼
1849630

從高級白內障手術市場報告(2025年):2024年到2030年前幾名13個國家的分析

2025 Premium Cataract Surgery Market Report: Analysis of the Top 13 Countries for 2024 to 2030

出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

最新發布

"高端白內障手術市場報告(2025)" 提供了13個主要國家/地區過去七年的歷史數據以及未來五年的預測數據,涵蓋了後房型人工水晶體(PC-IOL)、散光矯正型人工水晶體(Toric IOL)和飛秒雷射輔助等內障手術(FLACSS)

本版本新增了多項分析,旨在為策略決策提供指導,包括PCS推廣策略、外科醫生招募模式、高端人工水晶體選擇方法,以及自2005年以來LASIK術後和高端人工水晶體手術量,從而揭示推動PCS需求的人口統計因素。

該報告還涵蓋了市場趨勢,例如韓國和日本的PCS手術復甦、Lensar Ally等新型飛秒雷射輔助白內障手術(FLACS)的影響、包括嬰兒潮一代推動屈光性晶狀體置換術在內的人口結構變化,以及增長最快的優質人工晶狀體擴張——RxSight

"高階白內障手術市場報告(2025)" 清楚展現了全球主要的PCS市場,涵蓋13個國家,這些國家佔全球PCS製造商收入的84%。從美國和中國到日本、德國和其他國家,每個市場都得到了詳細分析,重點介紹了關鍵趨勢、成長驅動因素和戰略機會。

本報告重點關注對評估市場潛力或計劃推出關鍵白內障手術設備的公司而言最重要的因素,並提供實用見解以指導投資和擴張決策。

內容

高階白內障手術市場報告(2025) 對全球高階白內障手術市場進行了全面研究,揭示了關鍵趨勢、市場動態以及企業和供應商的策略機會。本報告結合全球洞察和深入的國別分析,旨在指導企業在這個快速發展的市場中進行決策和投資。

主要亮點包括:

  • 高端人工水晶體和技術老花眼矯正、散光矯正、中距離優化、術後可調節人工水晶體、飛秒雷射輔助白內障手術(FLACS)雷射和弧形切口、手動分離邊緣松解切口以及準分子雷射人工水晶體增強。
  • 主要市場概況:美國、中國、日本、法國、德國、巴西、加拿大、印度、西班牙、韓國、澳洲、英國和義大利這13個最大的白內障手術(PCS)市場的詳細概覽和摘要整理。
  • 市場和財務分析:各國白內障手術量預測、製造商收入、醫療機構收入以及公立和私立白內障手術方案的成本比較。
  • 醫療機構與外科醫師洞察:各主要市場中,按外科醫師劃分的白內障手術量細分,包括單純白內障手術、白內障/屈光手術以及單純屈光手術。
  • 競爭格局:各國及全球製造商的收入佔有率,以及最重要的白內障眼科醫院和診所清單。
  • 新興市場:以市場規模排名的六個最重要的白內障手術國家概覽。

信息圖形


簡介目錄

What's New:

The "2025 Premium Cataract Surgery Market Report" provides an updated, expanded view of the world's top PCS markets, providing seven years of historical data and five-year forecasts for PC-IOL, toric IOL, and FLACS procedures across 13 key countries.

This edition adds new analyses to guide strategic decisions, including PCS promotion strategies, surgeon adoption patterns, and premium IOL selection methodologies, along with post LASIK and premium IOL surgery volumes since 2005 to highlight the population driving PCS demand.

The report also covers market trends such as the recovery of PCS procedures in South Korea and Japan, the impact of new FLACS lasers like the Lensar Ally, demographic drivers including baby boomers fueling refractive lens exchange, and the fastest-growing premium IOL, the RxSight post-op adjustable lens, expanding into Canada, South Korea, and Singapore.

The "2025 Premium Cataract Surgery Market Report" delivers a clear view of the world's leading PCS markets, covering 13 countries that together generate 84 percent of global PCS manufacturer revenue. From the United States and China to Japan, Germany, and beyond, each market is analyzed in depth, highlighting key trends, growth drivers, and strategic opportunities.

The report zeroes in on the factors that matter most for companies evaluating market potential or planning to launch premium cataract surgery devices, providing actionable insights to guide investment and expansion decisions.

Contents:

The "2025 Premium Cataract Surgery Market Report" offers a comprehensive look at the global PCS landscape, highlighting key trends, market dynamics, and strategic opportunities for companies and providers. The report combines global insights with deep, country-level analysis to guide decision-making and investment in this rapidly evolving market.

Key highlights include:

  • Premium IOLs and technologies: Presbyopia-correcting, toric, intermediate-optimized, and post-op adjustable lenses; FLACS lasers and arcuate incisions; manual limbal relaxing incisions; and excimer IOL enhancements.
  • Top market profiles: In-depth snapshots and executive summaries for the 13 largest PCS markets-United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
  • Market and financial analysis: Country-specific forecasts for PCS procedures, manufacturer revenue, and provider revenue; cost comparisons for public and private cataract surgery options.
  • Provider and surgeon insights: Breakdown of PCS procedures by cataract-only, cataract/refractive, and refractive-only surgeons in each key market.
  • Competitive landscape: Manufacturer revenue shares by country and globally, plus a listing of the most important PCS eye hospitals and clinics.
  • Emerging markets: Overview of the next six most significant PCS countries ranked by market size.

INFOGRAPHICS